[Qisda] Announcement on the Resolution of the 2026 Annual General Meeting Regarding the Removal of Non-Compete Restrictions for New Directors and Their Representatives

1. Date of the shareholders' meeting: 2026/05/29. 2. Names and titles of directors permitted to engage in competitive activities: Chen Chi-hung, Huang Han-chou, AUO representative Chen Chien-pin, BenQ Foundation representative Ko Shu-fen, and independent directors Yen Lou-yu, Hsu Chueh-min, Chen Liang-gee, Lin Chiu-lien, and Huang Shu-chun. 3. Scope of permitted competitive activities: Includes various board positions at subsidiaries and affiliated companies such as BenQ Medical Technology, Partner Tech, DFI, Alpha Networks, Hitron, BenQ Materials, Darfon, and hospitals in Nanjing and Suzhou. 4. Duration: During the term of office as a director or representative of the company. 5. Voting results: Passed by a majority of the shareholders present, representing more than two-thirds of the total issued shares, in accordance with Article 209 of the Company Act. 6. Mainland China operations: Directors Chen Chi-hung and Huang Han-chou hold positions in medical and biotech entities in Nanjing, Suzhou, and Shanghai. 7. Impact on financial and business operations: None.